[Pharmacokinetic, bacteriological and clinical studies of cefuzonam in the field of obstetrics and gynecology]. 1987

K Ito, and K Iida, and H Kondo, and K Noda, and M Hayasaki, and H Sumi, and N Kadomoto
Department of Obstetrics and Gynecology, School of Medicine, Gifu University.

To study the transfer of cefuzonam (CZON, L-105) into female genital organs, concentrations of the compound in pelvic dead space exudate were measured in cases of radical hysterectomy due to cervical cancer and analyzed by the two-compartment model. When CZON 1 g was drip-infused intravenously, the concentration in the cubital vein blood was 46.95 micrograms/ml at 1 hour after the start of infusion. Concentrations in the pelvic dead space exudate reached the peak of 11.29 micrograms/ml at 2.44 hours after the start, were higher than 4 micrograms/ml after 8 hours and were higher than 1.7 micrograms/ml after 12 hours. The area under the concentration-time curve in the pelvic dead space exudate was 77.85 micrograms X hr/ml. From these results CZON was considered to be effective when administered at 1 g against infections of Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Proteus vulgaris, and haemophilus influenzae, but increased dose levels seemed necessary against infections of Staphylococcus epidermidis and Bacteroides fragilis. In 3 cases of obstetric and gynecological infections the efficacy of CZON was good in 2 cases and unknown in the other case.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010388 Pelvis The space or compartment surrounded by the pelvic girdle (bony pelvis). It is subdivided into the greater pelvis and LESSER PELVIS. The pelvic girdle is formed by the PELVIC BONES and SACRUM. Pelvic Region,Region, Pelvic
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D005122 Exudates and Transudates Exudates are fluids, CELLS, or other cellular substances that are slowly discharged from BLOOD VESSELS usually from inflamed tissues. Transudates are fluids that pass through a membrane or squeeze through tissue or into the EXTRACELLULAR SPACE of TISSUES. Transudates are thin and watery and contain few cells or PROTEINS. Transudates,Exudates,Transudates and Exudates,Exudate,Transudate
D005260 Female Females
D005831 Genital Diseases, Female Pathological processes involving the female reproductive tract (GENITALIA, FEMALE). Gynecologic Diseases,Female Genital Diseases,Diseases, Female Genital,Diseases, Gynecologic,Female Genital Disease,Genital Disease, Female,Gynecologic Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

K Ito, and K Iida, and H Kondo, and K Noda, and M Hayasaki, and H Sumi, and N Kadomoto
August 1988, The Japanese journal of antibiotics,
K Ito, and K Iida, and H Kondo, and K Noda, and M Hayasaki, and H Sumi, and N Kadomoto
May 1987, The Japanese journal of antibiotics,
K Ito, and K Iida, and H Kondo, and K Noda, and M Hayasaki, and H Sumi, and N Kadomoto
August 1988, The Japanese journal of antibiotics,
K Ito, and K Iida, and H Kondo, and K Noda, and M Hayasaki, and H Sumi, and N Kadomoto
January 1988, The Japanese journal of antibiotics,
K Ito, and K Iida, and H Kondo, and K Noda, and M Hayasaki, and H Sumi, and N Kadomoto
May 1987, The Japanese journal of antibiotics,
K Ito, and K Iida, and H Kondo, and K Noda, and M Hayasaki, and H Sumi, and N Kadomoto
May 1987, The Japanese journal of antibiotics,
K Ito, and K Iida, and H Kondo, and K Noda, and M Hayasaki, and H Sumi, and N Kadomoto
September 1987, The Japanese journal of antibiotics,
K Ito, and K Iida, and H Kondo, and K Noda, and M Hayasaki, and H Sumi, and N Kadomoto
May 1987, The Japanese journal of antibiotics,
K Ito, and K Iida, and H Kondo, and K Noda, and M Hayasaki, and H Sumi, and N Kadomoto
September 1987, The Japanese journal of antibiotics,
K Ito, and K Iida, and H Kondo, and K Noda, and M Hayasaki, and H Sumi, and N Kadomoto
August 1988, The Japanese journal of antibiotics,
Copied contents to your clipboard!